Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Proteomics International Laboratories Ltd. ( (AU:PIQ) ) has shared an update.
Proteomics International Laboratories Ltd has released its Corporate Governance Statement and Appendix 4G in compliance with ASX Listing Rules. This announcement, authorized by the company’s Board of Directors, underscores the company’s adherence to corporate governance standards, which is crucial for maintaining investor confidence and ensuring transparency in its operations.
The most recent analyst rating on (AU:PIQ) stock is a Hold with a A$0.43 price target. To see the full list of analyst forecasts on Proteomics International Laboratories Ltd. stock, see the AU:PIQ Stock Forecast page.
More about Proteomics International Laboratories Ltd.
Proteomics International Laboratories Ltd is a company operating in the biotechnology industry, focusing on proteomics, which involves the large-scale study of proteins. The company is part of the PILL Group and is based in Australia.
Average Trading Volume: 368,695
Technical Sentiment Signal: Sell
Current Market Cap: A$51.56M
Learn more about PIQ stock on TipRanks’ Stock Analysis page.